These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 11040225)

  • 21. Adrenal and circulating renin-angiotensin system in stroke-prone hypertensive rats.
    Kim S; Tokuyama M; Hosoi M; Yamamoto K
    Hypertension; 1992 Sep; 20(3):280-91. PubMed ID: 1516946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats.
    Naruse M; Tanabe A; Sato A; Takagi S; Tsuchiya K; Imaki T; Takano K
    Hypertension; 2002 Jul; 40(1):28-33. PubMed ID: 12105134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes.
    Harada E; Yoshimura M; Yasue H; Nakagawa O; Nakagawa M; Harada M; Mizuno Y; Nakayama M; Shimasaki Y; Ito T; Nakamura S; Kuwahara K; Saito Y; Nakao K; Ogawa H
    Circulation; 2001 Jul; 104(2):137-9. PubMed ID: 11447075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
    Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Ishimura Y; Chatani F; Iwao H
    J Pharmacol Exp Ther; 1995 Apr; 273(1):509-15. PubMed ID: 7714806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of cardiac angiotensin I-converting enzyme with dietary NaCl-loading in genetically hypertensive and normotensive rats.
    Kreutz R; Fernandez-Alfonso MS; Liu Y; Ganten D; Paul M
    J Mol Med (Berl); 1995 May; 73(5):243-8. PubMed ID: 7670928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A twofold genetic increase of ACE expression has no effect on the development of spontaneous hypertension.
    Nassar I; Schulz A; Bernardy C; Garrelds IM; Plehm R; Huber M; Danser AH; Kreutz R
    Am J Hypertens; 2008 Feb; 21(2):200-5. PubMed ID: 18174884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
    Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
    Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of medium-chain triglyceride (MCT) application to SHR on cardiac function, hypertrophy and expression of endothelin-1 mRNA and other genes.
    Shimojo N; Miyauchi T; Iemitsu M; Irukayama-Tomobe Y; Maeda S; Ohkubo T; Tanaka Y; Goto K; Yamaguchi I
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S181-5. PubMed ID: 15838274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased production of angiotensin II in the adrenal gland of stroke-prone spontaneously hypertensive rats with malignant hypertension.
    Kim S; Hosoi M; Shimamoto K; Takada T; Yamamoto K
    Biochem Biophys Res Commun; 1991 Jul; 178(1):151-7. PubMed ID: 2069554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A heart-specific increase in cardiotrophin-1 gene expression precedes the establishment of ventricular hypertrophy in genetically hypertensive rats.
    Ishikawa M; Saito Y; Miyamoto Y; Harada M; Kuwahara K; Ogawa E; Nakagawa O; Hamanaka I; Kajiyama N; Takahashi N; Masuda I; Hashimoto T; Sakai O; Hosoya T; Nakao K
    J Hypertens; 1999 Jun; 17(6):807-16. PubMed ID: 10459879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined effects of low-dose oral spironolactone and captopril therapy in a rat model of spontaneous hypertension and heart failure.
    Kambara A; Holycross BJ; Wung P; Schanbacher B; Ghosh S; McCune SA; Bauer JA; Kwiatkowski P
    J Cardiovasc Pharmacol; 2003 Jun; 41(6):830-7. PubMed ID: 12775959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart.
    Rocha R; Martin-Berger CL; Yang P; Scherrer R; Delyani J; McMahon E
    Endocrinology; 2002 Dec; 143(12):4828-36. PubMed ID: 12446610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-related changes in cardiac expression of VEGF and its angiogenic receptor KDR in stroke-prone spontaneously hypertensive rats.
    Jesmin S; Hattori Y; Togashi H; Ueno K; Yoshioka M; Sakuma I
    Mol Cell Biochem; 2005 Apr; 272(1-2):63-73. PubMed ID: 16010973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of RAAS antagonist on the expression of gap junction cx43 in myocardium of spontaneously hypertensive rat].
    Tan LL; Li L; Liu LM; Zhao HL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 44(4):531-5, 549. PubMed ID: 24059102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.
    Luther JM; Luo P; Wang Z; Cohen SE; Kim HS; Fogo AB; Brown NJ
    Kidney Int; 2012 Sep; 82(6):643-51. PubMed ID: 22622494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension.
    Dominiczak AF; Devlin AM; Lee WK; Anderson NH; Bohr DF; Reid JL
    Hypertension; 1996 Mar; 27(3 Pt 2):752-9. PubMed ID: 8613236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage.
    Fiebeler A; Nussberger J; Shagdarsuren E; Rong S; Hilfenhaus G; Al-Saadi N; Dechend R; Wellner M; Meiners S; Maser-Gluth C; Jeng AY; Webb RL; Luft FC; Muller DN
    Circulation; 2005 Jun; 111(23):3087-94. PubMed ID: 15939810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
    Endemann DH; Touyz RM; Iglarz M; Savoia C; Schiffrin EL
    Hypertension; 2004 Jun; 43(6):1252-7. PubMed ID: 15117913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deficiency of T-type Ca
    Thuesen AD; Finsen SH; Rasmussen LL; Andersen DC; Jensen BL; Hansen PBL
    Am J Physiol Renal Physiol; 2019 Aug; 317(2):F254-F263. PubMed ID: 31042060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Important role of angiotensin II-mediated c-Jun NH(2)-terminal kinase activation in cardiac hypertrophy in hypertensive rats.
    Izumi Y; Kim S; Zhan Y; Namba M; Yasumoto H; Iwao H
    Hypertension; 2000 Oct; 36(4):511-6. PubMed ID: 11040228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.